That's pretty much it.
http://finance.yahoo.com/news/mesoblast-price-target-raised-14-122628577.html
"Maxim raised its price target for Mesoblast to reflect the company's acquisition of Prochymal and keeps a Buy rating on the stock."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
0.020(1.18%) |
Mkt cap ! $2.185B | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.72 | $1.64 | $3.250M | 1.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 63491 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.72 | 124199 | 39 |
View Market Depth
| Last trade - 15.41pm 16/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |